IRONWOOD PHARMACEUTICALS INC·4

Mar 10, 5:10 PM ET

John Minardo 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Mar 10, 2023

Insider Transaction Report

Form 4
Period: 2023-03-08
John Minardo
Chief Legal Officer
Transactions
  • Award

    Performance-based Restricted Stock Units

    2023-03-08+32,75132,751 total
    Exp: 2026-02-28Class A Common Stock (32,751 underlying)
  • Award

    Class A Common Stock

    2023-03-08+65,502199,240 total
Footnotes (2)
  • [F1]The restricted stock unit award, granted as an annual performance award, vests as to 25% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.
  • [F2]Each performance-based restricted stock unit (PSU) represents a contingent right to receive shares of the Issuer's Class A Common Stock upon vesting such award. The PSUs vest upon the Issuer's Class A Common Stock achieving a specified price per share.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION